Clinical trial
Use of a TGA and TEM in the Assessment of the Efficacy of Treatment With APCC or rFVIIa Concentrate in Patients With Acquired Haemophilia and in Patients With Haemophilia A With Inhibitors
NCT01856751 is registered in ClinicalTrials.gov with Stowarzyszenie Pomocy Chorym na Zakrzepicę i Skazy Krwotoczne Thrombus as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Use of a TGA and TEM in the Assessment of the Efficacy of Treatment With APCC or rFVIIa Concentrate in Patients With Acquired Haemophilia and in Patients With Haemophilia A With Inhibitors
- Lead sponsor
- Stowarzyszenie Pomocy Chorym na Zakrzepicę i Skazy Krwotoczne Thrombus
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- April 30, 2014
- Completion date
- June 30, 2016
- Enrollment
- 80 (estimated)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
haemophilia